CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression.
CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression.
复制标题
CircPTPRA 通过与 IGF2BP1 相互作用阻断 RNA N6-甲基腺苷的识别,从而抑制膀胱癌进展
DOI:
10.1186/s12943-021-01359-x
复制
发表时间:
2021-04-14
期刊:
影响因子:
37.3
通讯作者:
Jiang G
中科院分区:
文献类型:
--
作者:
Xie F;Huang C;Liu F;Zhang H;Xiao X;Sun J;Zhang X;Jiang G
Circular RNAs (circRNAs) have been found to have significant impacts on bladder cancer (BC) progression through various mechanisms. In this study, we aimed to identify novel circRNAs that regulate the function of IGF2BP1, a key m6A reader, and explore the regulatory mechanisms and clinical significances in BC. Firstly, the clinical role of IGF2BP1 in BC was studied. Then, RNA immunoprecipitation sequencing (RIP-seq) analysis was performed to identify the circRNAs interacted with IGF2BP1 in BC cells. The overall biological roles of IGF2BP1 and the candidate circPTPRA were investigated in both BC cell lines and animal xenograft studies. Subsequently, we evaluated the regulation effects of circPTPRA on IGF2BP1 and screened out its target genes through RNA sequencing. Finally, we explored the underlying molecular mechanisms that circPTPRA might act as a blocker in recognition of m6A. We demonstrated that IGF2BP1 was predominantly binded with circPTPRA in the cytoplasm in BC cells. Ectopic expression of circPTPRA abolished the promotion of cell proliferation, migration and invasion of BC cells induced by IGF2BP1. Importantly, circPTPRA downregulated IGF2BP1-regulation of MYC and FSCN1 expression via interacting with IGF2BP1. Moreover, the recognition of m6A-modified RNAs mediated by IGF2BP1 was partly disturbed by circPTPRA through its interaction with KH domains of IGF2BP1. This study identifies exonic circular circPTPRA as a new tumor suppressor that inhibits cancer progression through endogenous blocking the recognition of IGF2BP1 to m6A-modified RNAs, indicating that circPTPRA may serve as an exploitable therapeutic target for patients with BC. The online version contains supplementary material available at 10.1186/s12943-021-01359-x.
登录
查看更多内容
影响因子:
254.7
作者:
Jemal, Ahmedin;Siegel, Rebecca;Thun, Michael J.
通讯作者:
Thun, Michael J.
影响因子:
11.1
作者:
Mahe M;Dufour F;Neyret-Kahn H;Moreno-Vega A;Beraud C;Shi M;Hamaidi I;Sanchez-Quiles V;Krucker C;Dorland-Galliot M;Chapeaublanc E;Nicolle R;Lang H;Pouponnot C;Massfelder T;Radvanyi F;Bernard-Pierrot I
通讯作者:
Bernard-Pierrot I
影响因子:
5.3
作者:
Lemm, I;Ross, J
通讯作者:
Ross, J
影响因子:
64.5
作者:
Meyer KD;Patil DP;Zhou J;Zinoviev A;Skabkin MA;Elemento O;Pestova TV;Qian SB;Jaffrey SR
通讯作者:
Jaffrey SR
影响因子:
2.3
作者:
Li, Yang;Xu, Zhiwen;Zhu, Minghui
通讯作者:
Zhu, Minghui